News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
JONES WILLIAM A JR
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/07/2022 |
4
| JONES WILLIAM A JR (CCO-Migraine & Common Disease) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.
Txns:
| Paid exercise price by delivering 2,230 shares
@ $123.86, valued at
$276.2k
Paid exercise price by delivering 1,631 shares
@ $128.87, valued at
$210.2k
Exercised 5,000 options to buy
@ $0 Granted 30,000 options to buy
@ $128.87, valued at
$3.9M
Granted 15,000 options to buy
@ $0 Exercised 3,750 options to buy
@ $0 |
|
11/26/2021 |
4
| JONES WILLIAM A JR (CCO-Migraine & Common Disease) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.
Txns:
| Paid exercise price by delivering 1,305 shares
@ $115.55, valued at
$150.8k
Exercised 3,000 options to buy
@ $0 |
|
01/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/27/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/04/2020 |
4
| JONES WILLIAM A JR (CCO-Migraine & Common Disease) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.
Txns:
| Sold 24,690 shares
@ $76.0175, valued at
$1.9M
Sold 4,010 shares
@ $77.0073, valued at
$308.8k
Sold 1,300 shares
@ $77.6962, valued at
$101k
Exercised 30,000 options to buy
@ $50.72, valued at
$1.5M
|
|
12/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/03/2019 |
4
| JONES WILLIAM A JR (CCO-Migraine & Common Disease) has filed a Form 4 on Biohaven Pharmaceutical Holding Co Ltd.
Txns:
| Granted 80,000 options to buy
@ $50.72, valued at
$4.1M
|
|
|
|